Qualigen Therapeutics Inc. buy Maxfloh
Start price
07.01.18
/
50%
€710.33
Target price
05.11.18
€1,353.0
Performance (%)
-61.27%
End price
05.11.18
€275.10
Summary
This prediction ended on 05.11.18 with a price of €275.10. The BUY prediction by Maxfloh for Qualigen Therapeutics Inc. performed very badly with a performance of -61.27%. Maxfloh has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Qualigen Therapeutics Inc. | -10.000% | -10.000% | -81.143% | -98.680% |
iShares Core DAX® | -5.744% | -6.037% | 9.155% | 8.257% |
iShares Nasdaq 100 | -4.907% | -12.083% | 19.607% | 30.219% |
iShares Nikkei 225® | -7.230% | -10.182% | 3.445% | -1.121% |
iShares S&P 500 | -4.764% | -6.545% | 19.194% | 31.957% |
Comments by Maxfloh for this prediction
In the thread Ritter Pharmaceuticals Inc diskutieren
Pleitekandidat oder Vervielfacher?
- günstige Marktkapitalisierung
- Kapitalerhöhung ist erfolgreich verlaufen
- beginn der Phase 3 Studie von RP-G28 ab Frühjahr 2018
Ritter Pharmaceuticals ist ein führender Pharmaforscher im Bereich der Laktoseintoleranz
(Vom Mitglied beendet)
Stopped prediction by Maxfloh for Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.20
19.08.19
19.08.19
€400.00
13.09.19
13.09.19
-
13.09.19
13.09.19